| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/26/2011 | US7931863 Sample analyzer |
| 04/26/2011 | US7931861 Sample analyzer |
| 04/26/2011 | US7931613 Module for a computer interface |
| 04/26/2011 | US7931592 Systems and methods for monitoring health and delivering drugs transdermally |
| 04/26/2011 | US7930948 Device for leaching extraction and assessment |
| 04/26/2011 | US7930927 Transdermal portable alcohol monitor and methods for using such |
| 04/26/2011 | US7930923 Quartz crystal microbalance with nanocrystalline oxide semiconductor thin films and method of detecting vapors and odors including alcoholic beverages, explosive materials and volatilized chemical compounds |
| 04/26/2011 | CA2677953C Composite arrays utilizing microspheres with a hybridization chamber |
| 04/26/2011 | CA2615768C Methods and apparatus for maintaining effective operation of apparatus for candling avian eggs |
| 04/26/2011 | CA2543350C Disintegratable films for diagnostic devices |
| 04/26/2011 | CA2477722C Detection of odours |
| 04/26/2011 | CA2476308C Autonomous, ambulatory analyte monitor or drug delivery device |
| 04/26/2011 | CA2462932C Method for the detection of cytosine methylations in immobilized dna samples |
| 04/26/2011 | CA2461587C Materials and methods for controlling isotope effects during fractionation of analytes |
| 04/26/2011 | CA2446112C A method for regulating immune function in primates using the foxp3 protein |
| 04/26/2011 | CA2439085C Methods for identifying ligand binding sites in a biomolecule |
| 04/26/2011 | CA2402099C Methods for the treatment of primary headache disorders using prostanoid ep4 receptor antagonists, and assays for agents for such treatment |
| 04/26/2011 | CA2401164C Combined lancet and electrochemical analyte-testing apparatus |
| 04/26/2011 | CA2370122C Rapid and efficient capture of dna from sample without using cell lysing reagent |
| 04/26/2011 | CA2326141C Use of receptor of a ror family for screening substances useful for the treatment of atherosclerosis |
| 04/26/2011 | CA2215394C Il-17 receptor |
| 04/26/2011 | CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/22/2011 | CA2740828A1 Determination of the salt concentration of an aqueous solution |
| 04/21/2011 | WO2011047386A1 Direct hierarchical assembly of nanoparticles |
| 04/21/2011 | WO2011047337A2 Cell-based complement activation product algorithm for diagnosing systemic lupus erythematosus |
| 04/21/2011 | WO2011047314A2 Cell for broadband dielectric spectroscopy |
| 04/21/2011 | WO2011047271A1 Multi-channel potentiostat for biosensor arrays |
| 04/21/2011 | WO2011047266A1 Il-1 binding proteins |
| 04/21/2011 | WO2011047265A1 Resonance energy transfer assay with synaptobrevin substrate moiety |
| 04/21/2011 | WO2011047246A2 Reconfigurable water flushing and sampling device |
| 04/21/2011 | WO2011047223A1 Methods of polynucleotide detection |
| 04/21/2011 | WO2011047192A2 Protected amine labels and use in detecting analytes |
| 04/21/2011 | WO2011047150A1 Mass spectrometry quantitation of p450 protein isoforms in hepatocytes |
| 04/21/2011 | WO2011047112A1 Measurement of pka for cancer detection |
| 04/21/2011 | WO2011047087A2 Protein detection via nanoreporters |
| 04/21/2011 | WO2011047073A2 Assessing rheumatoid arthritis |
| 04/21/2011 | WO2011047033A2 Biomarker for identification of melanoma tumor cells |
| 04/21/2011 | WO2011047023A2 Enhanced microplate configurations |
| 04/21/2011 | WO2011047020A1 Multisite biosensor and associated method |
| 04/21/2011 | WO2011047019A1 An objective, quantitative method to predict histological subtype in non-small cell lung cancer |
| 04/21/2011 | WO2011046943A1 Bromothymol blue composition for detection of free radicals |
| 04/21/2011 | WO2011046871A1 Quantification of ir-a and ir-b for tumor classification |
| 04/21/2011 | WO2011046850A1 Onset haze measurement apparatus and procedure |
| 04/21/2011 | WO2011046834A1 In-vivo platelet function test by online bleeding volume measurement |
| 04/21/2011 | WO2011046807A2 Multi-modality contrast and brightfield context rendering for enhanced pathology determination and multi-analyte detection in tissue |
| 04/21/2011 | WO2011046760A1 Electrospun fiber pre-concentrator |
| 04/21/2011 | WO2011046706A1 Bare single-layer graphene membrane having a nanopore enabling high-sensitivity molecular detection and analysis |
| 04/21/2011 | WO2011046652A2 All-protein implantable, resorbable reflectors |
| 04/21/2011 | WO2011046624A2 Triangulation of pavement deflections using more than four sensors |
| 04/21/2011 | WO2011046622A2 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide |
| 04/21/2011 | WO2011046597A2 Biomarkers for the detection of breast cancer |
| 04/21/2011 | WO2011046595A1 Methods for identifying animals with a reduced ability to digest lipid and protein |
| 04/21/2011 | WO2011046534A1 Correlating push force and stalk vibration to a plant's susceptibility to stalk lodging and brittle snap |
| 04/21/2011 | WO2011046533A1 Correlating push force and stalk vibration to a plant's susceptibility to root lodging, stalk/stem lodging and brittle snap (broken stems or stalks) |
| 04/21/2011 | WO2011046382A2 Nrf2 inhibitors and use thereof |
| 04/21/2011 | WO2011046309A2 A diagnostic marker for hepatocellular carcinoma comprising anti-fasn autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof |
| 04/21/2011 | WO2011046221A1 INTERFERON-α MODULATOR |
| 04/21/2011 | WO2011046207A1 Examination device and examination method |
| 04/21/2011 | WO2011046204A1 Marker associated with non-alcoholic steatohepatitis |
| 04/21/2011 | WO2011046193A1 Aptamer capable of binding to viral hemorrhagic septicemia virus |
| 04/21/2011 | WO2011046160A1 Method for screening of substance capable of preventing virus infection, and agent for preventing virus infection |
| 04/21/2011 | WO2011046005A1 Device and method for measuring molecular composition |
| 04/21/2011 | WO2011045945A1 ANTIBODY RECOGNIZING TURN STRUCTURE IN AMYLOID β |
| 04/21/2011 | WO2011045937A1 Method and marker for determination of degree of risk of onset of high-functioning autism |
| 04/21/2011 | WO2011045745A1 Antibody associated with autoimmune pancreatitis and uses thereof |
| 04/21/2011 | WO2011045704A1 Cancer treatment |
| 04/21/2011 | WO2011045700A1 Methods and apparatus for downhole characterization of emulsion stability |
| 04/21/2011 | WO2011045573A2 Staphylococcal antigens |
| 04/21/2011 | WO2011045456A2 Novel biomarkers of disease histopathology |
| 04/21/2011 | WO2011045436A1 An assay method and devices involving the use of magnetic particles |
| 04/21/2011 | WO2011045396A2 Biomarkers of tumor pharmacodynamic response |
| 04/21/2011 | WO2011045394A1 Biomolecular labels, involving nanoparticles functionalised with dendrimers |
| 04/21/2011 | WO2011045348A1 Protection from hydrophobizing agents |
| 04/21/2011 | WO2011045305A1 Enzyme fragment complementation assays for monitoring the activation of the voltage-gated potassium ion channel herg |
| 04/21/2011 | WO2011045244A1 Acute kidney injury risk testing |
| 04/21/2011 | WO2011045166A1 Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction |
| 04/21/2011 | WO2011045056A1 Methods for prrsv detection |
| 04/21/2011 | WO2011045022A1 Assay and device therefor |
| 04/21/2011 | WO2011045005A1 Method and apparatus for monitoring cement sheath degradation related to co2 exposure |
| 04/21/2011 | WO2011044904A2 Method of prognosis |
| 04/21/2011 | WO2011044654A1 Phosphorylation of the estrogen receptor alpha serine 282 as a marker for endocrine therapies in breast cancer |
| 04/21/2011 | WO2011044653A1 Phosphorylation of estrogen receptor alpha |
| 04/21/2011 | WO2011044649A1 Method for preparing a faecal copro-parasitological specimen, and clarifying composition |
| 04/21/2011 | WO2011026132A3 Methods and compositions for the inhibition of transplant rejection |
| 04/21/2011 | WO2011026085A3 Reactive cyanine compounds |
| 04/21/2011 | WO2011022121A3 Analyte sensor fabrication |
| 04/21/2011 | WO2011022093A3 Methods and devices for detecting the presence of an analyte in a sample |
| 04/21/2011 | WO2011021779A3 Method for evaluating water quality and toxicity using the growth rate of germ tubes of spores of algae belonging to the order laminariales |
| 04/21/2011 | WO2011021778A3 Method for evaluating water quality and toxicity using the germination rate of spores of algae belonging to the order laminariales, and kit for evaluating water quality and toxicity |
| 04/21/2011 | WO2011018710A3 Biological components within the cerebrospinal fluid |
| 04/21/2011 | WO2011014299A3 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 04/21/2011 | WO2011011054A3 Correction for gas entrained water analyzers |
| 04/21/2011 | WO2011010868A3 Novel biopolymer crystallization plate, biopolymer crystallization method using same, and method for directly collecting x-ray diffraction data from the biopolymer crystal generated by same |
| 04/21/2011 | WO2011008581A3 Devices, methods, and kits for determining analyte concentrations |
| 04/21/2011 | WO2011005882A3 Cascaded gas chromatographs (cgcs) with individual temperature control and gas analysis systems using same |
| 04/21/2011 | WO2010151780A3 Methods and systems for using actuated surface-attached posts for assessing biofluid rheology |
| 04/21/2011 | WO2010148020A3 Detection of occult blood in feces or urine |
| 04/21/2011 | WO2010144507A3 Rapid detection of cerebrospinal fluid, methods and systems therefore |
| 04/21/2011 | WO2010144324A3 Use of stamp related molecules in the diagnosis and inhibition of ovarian cancer cells |
| 04/21/2011 | WO2010141862A3 Methods and materials for isolating exosomes |